Your session is about to expire
← Back to Search
Tumor biopsy for Non-Small Cell Lung Cancer
Study Summary
This trial will collect tumor tissue and blood samples from people with advanced cancer to study the disease at a molecular level.
- Non-Small Cell Lung Cancer
- Tumors
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 2 trial • 19 Patients • NCT00244933Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it risky to have a Tumor biopsy?
"While there is some data supporting the safety of a tumor biopsy, as this is only a phase 2 trial, none of the available information suggests that the procedure is effective."
Are there any available positions for participants in this trial?
"The clinicaltrials.gov website indicates that this trial is currently looking for patients to enroll. The study was originally posted on May 25th, 2021 and was updated as recently as August 11th, 2022."
How many individuals are being recruited for this research project?
"The listing on clinicaltrials.gov indeed suggests that this study is still enrolling patients. The trial was first advertised on May 25th, 2021 and edited as recently as August 11th, 2022. They are looking for 400 people to participate at 1 location."
Share this study with friends
Copy Link
Messenger